Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies
Data up to Jan 2025
Total Citations Per Year
Abstract
References (61)
Use of Arsenic Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients
1997 • 1,431 citations
Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide
1998 • 1,220 citations
Role of the histone deacetylase complex in acute promyelocytic leukaemia
1998 • 1,091 citations
Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia
1998 • 1,021 citations
United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia
2001 • 825 citations
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL) : I. As2O3 exerts dose-dependent dual effects on APL cells
1997 • 808 citations
A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
1994 • 798 citations
Acute Promyelocytic Leukemia
2015 • 764 citations
Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus
1998 • 676 citations
Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells
1994 • 668 citations
Studies on Treatment of Acute Promyelocytic Leukemia With Arsenic Trioxide: Remission Induction, Follow-Up, and Molecular Monitoring in 11 Newly Diagnosed and 47 Relapsed Acute Promyelocytic Leukemia Patients
1999 • 630 citations
All-trans retinoic acid/As 2 O 3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia
2004 • 573 citations
Pml is essential for multiple apoptotic pathways
1998 • 564 citations
Arsenic Trioxide Selectively Induces Acute Promyelocytic Leukemia Cell Apoptosis Via a Hydrogen Peroxide-Dependent Pathway
1999 • 539 citations
Malignant Cells Can Be Sensitized to Undergo Growth Inhibition and Apoptosis by Arsenic Trioxide Through Modulation of the Glutathione Redox System
1999 • 538 citations
Role of PML in Cell Growth and the Retinoic Acid Pathway
1998 • 522 citations
Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia
2003 • 496 citations
Role of Promyelocytic Leukemia (Pml) Sumolation in Nuclear Body Formation, 11s Proteasome Recruitment, and as2O3-Induced Pml or Pml/Retinoic Acid Receptor α Degradation
2001 • 477 citations
Arsenic-induced PML targeting onto nuclear bodies: Implications for the treatment of acute promyelocytic leukemia
1997 • 430 citations
Mutagenicity of arsenic in mammalian cells: Role of reactive oxygen species
1998 • 423 citations
PML induces a novel caspase-independent death process
1998 • 384 citations
History of the Development of Arsenic Derivatives in Cancer Therapy
2001 • 347 citations
How acute promyelocytic leukaemia revived arsenic
2002 • 318 citations
Higher Frequency of Glutathione S-Transferase Deletions in Black Children With Acute Lymphoblastic Leukemia
1997 • 310 citations
Mechanisms of Arsenic-Induced Prolongation of Cardiac Repolarization
2004 • 281 citations
Ascorbic acid enhances arsenic trioxide–induced cytotoxicity in multiple myeloma cells
2001 • 275 citations
Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma
2002 • 260 citations
Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells
2004 • 228 citations
Effect of Arsenic Trioxide on QT Interval in Patients With Advanced Malignancies
2003 • 224 citations
Oxidative Stress Contributes to Arsenic-induced Telomere Attrition, Chromosome Instability, and Apoptosis
2003 • 214 citations
Clinical Trials of Arsenic Trioxide in Hematologic and Solid Tumors: Overview of the National Cancer Institute Cooperative Research and Development Studies
2001 • 213 citations
Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report
2002 • 211 citations
Arsenic trioxide–induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL
2003 • 210 citations
Arsenic induces apoptosis through a c-Jun NH2-terminal kinase-dependent, p53-independent pathway.
1999 • 183 citations
Arsenic Trioxide and Interferon- Synergize to Induce Cell Cycle Arrest and Apoptosis in Human T-Cell Lymphotropic Virus Type I–Transformed Cells
1999 • 181 citations
Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine
2004 • 177 citations
Role of oxidative damage in the genotoxicity of arsenic
2004 • 166 citations
Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis
2003 • 156 citations
Combined Treatment With Arsenic Trioxide and All-Trans-Retinoic Acid in Patients With Relapsed Acute Promyelocytic Leukemia
2003 • 154 citations
JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells
2004 • 152 citations
A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells
2003 • 147 citations
Arsenic-interferon-α–triggered apoptosis in HTLV-I transformed cells is associated with Tax down-regulation and reversal of NF-κB activation
2000 • 146 citations
Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis
2004 • 134 citations
Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia
1998 • 133 citations
Arsenic inhibition of telomerase transcription leads to genetic instability
2001 • 121 citations
Two distinctly regulated events, priming and triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic leukemia cell line.
1994 • 111 citations
The theory of APL
2001 • 106 citations
PIC-1/SUMO-1-Modified PML-Retinoic Acid Receptor α Mediates Arsenic Trioxide-Induced Apoptosis in Acute Promyelocytic Leukemia
1999 • 104 citations
In Vivo Activation of cAMP Signaling Induces Growth Arrest and Differentiation in Acute Promyelocytic Leukemia
2002 • 101 citations
Arsenic Trioxide Induces G2/M Growth Arrest and Apoptosis after Caspase-3 Activation and Bcl-2 Phosphorylation in Promonocytic U937 Cells
2001 • 98 citations
Synergic effects of arsenic trioxide and cAMP during acute promyelocytic leukemia cell maturation subtends a novel signaling cross-talk
2002 • 90 citations
Docosahexaenoic acid enhances arsenic trioxide–mediated apoptosis in arsenic trioxide–resistant HL-60 cells
2003 • 88 citations
Expanding the use of arsenic trioxide: Leukemias and beyond
2002 • 80 citations
Dithiothreitol Enhances Arsenic Trioxide-Induced Apoptosis in NB4 Cells
1999 • 61 citations
Arsenic Trioxide Is a Potent Inhibitor of the Interaction of SMRT Corepressor with Its Transcription Factor Partners, Including the PML-Retinoic Acid Receptor α Oncoprotein Found in Human Acute Promyelocytic Leukemia
2001 • 59 citations
Inhibition of coupling factor B activity by cadmium ion, arsenite-2,3-dimercaptopropanol, and phenylarsine oxide, and preferential reactivation by dithiols.
1981 • 58 citations
Advances in the Management of Acute Promyelocytic Leukemia and Other Hematologic Malignancies with Arsenic Trioxide
2002 • 35 citations
Activation Analyses of Authenticated Hairs of Napoleon Bonaparte Confirm Arsenic Poisoning
1999 • 31 citations
Inhibition of apoptosis in acute promyelocytic leukemia cells leads to increases in levels of oxidized protein and LMP2 immunoproteasome
2004 • 28 citations
Arsenic enhances the activation of Stat1 by interferon γ leading to synergistic expression of IRF-1
2003 • 28 citations
Homicidal Poisonings in the United States: An Analysis of the Uniform Crime Reports from 1980 through 1989
1996 • 21 citations